7.60% 0.79

Coeptis Therapeutics Holdings Inc (COEP)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Coeptis Therapeutics Holdings Inc-Aktie (COEP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.32% 0.2374	0.2007	0.0629	-	-
Cost Of Revenue	0.00% 0.0452	0.0452	0.0452	-	-
Gross Profit	23.64% 0.1923	0.1555	0.0177	-	-
Operating Expenses	42.92% 2.6693	4.6767	4.0747	2.1622	2.1418
Benefits Costs and Expenses	30.85% 3.1362	4.5353	3.4838	-	-
Costs And Expenses	30.85% 3.1362	4.5353	3.4838	-	-
Operating Income/Loss	45.21% -2.477	-4.5212	-4.057	-2.1622	-2.1418
Nonoperating Income/Loss	325.98% -0.4217	0.1866	0.636	-0.8496	0.3129
Income/Loss From Continuing Operations Before Tax	33.12% -2.8988	-4.3346	-3.4209	-3.0118	-1.8289
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	22.50% -2.7394	-3.5346	-3.0577	-1.948	-1.8289
Net Income/Loss	36.80% -2.7394	-4.3346	-3.4209	-1.948	-1.8289
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	80.08% 0.1594	0.80	0.3632	1.0638	-
Basic Average Shares	28.01% 4.7451	3.7068	3.0731	-35.72	39.81
Diluted Average Shares	28.01% 4.7451	3.7068	3.0731	-35.72	39.81
Basic Earnings Per Share	50.43% -0.58	-1.17	-1.11	-5.44	-0.05
Diluted Earnings Per Share	50.43% -0.58	-1.17	-1.11	-5.44	-0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-